Disease of the Year for 2023: Pediatric Uveitis

References

• Gentile P, Ragusa E, Bolletta E, et al. Epidemiology of pediatric uveitis. Ocul Immunol Inflamm. 2023;31(10):2050–2059. doi:10.1080/09273948.2023.2271988.
   Web of Science ®Google Scholar
• Yalçındağ FN, Özdal P, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I. Pediatric uveitis in Turkey: the national registry report II. Ocul Immunol Inflamm. 2023;31(10):1971–1977. doi:10.1080/09273948.2022.2110900.
   PubMed Web of Science ®Google Scholar
• Abd El Latif E, Mousa R, Tawfeeq Mahdi M, et al. Etiology of pediatric uveitis in a tertiary pediatric eye hospital in Egypt. Ocular Immunology And Inflammation. 2023;31(10):1978–1983. doi:10.1080/09273948.2022.2117201.
   PubMed Web of Science ®Google Scholar
• Kardes E, Sözeri B, Demir F, Akcay BIS. Risk factors for ocular complications and visual loss in patients with juvenile idiopathic arthritis-associated uveitis at a Turkish tertiary ophthalmology and pediatric rheumatology referral center. Ocul Immunol Inflamm. 2023;31(10):1984–1991. doi:10.1080/09273948.2022.2123833.
   PubMed Web of Science ®Google Scholar
• Wu PY, Kang EYC, Chen WD, et al. Epidemiology, treatment, and outcomes of juvenile idiopathic arthritis-associated uveitis: a multi-institutional study in Taiwan. Ocul Immunol Inflamm. 2023;31(10):2009–2017. doi:10.1080/09273948.2022.2162927.
   Web of Science ®Google Scholar
• Khazaei S, Bakhtiari E, Ansari Astaneh MR, Hosseini SM. Epidemiology and clinical course of pediatric uveitis in a tertiary referral center in northeastern Iran. Ocul Immunol Inflamm. 2023;31(10):2024–2031. doi:10.1080/09273948.2023.2249985.
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Yawata N, Hasegawa E, et al. Clinical features of pediatric uveitis at a tertiary referral center in the western region of Japan. Ocul Immunol Inflamm. 2023;31(10):2032–2038. doi:10.1080/09273948.2023.2273363.
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Aissopou EK, Chatzistefanou KI. Pediatric non-infectious uveitis: long-term outcomes and complications. Ocul Immunol Inflamm. 2023;31(10):2001–2008. doi:10.1080/09273948.2022.2162422.
   Web of Science ®Google Scholar
• Maccora I, Guly C, de Libero C, Caputo R, Ramanan AV, Simonini G. Childhood chronic idiopathic uveitis in a multicentre international cohort. Ocul Immunol Inflamm. February, 2023:1–10. doi:10.1080/09273948.2023.2169715.
   PubMed Web of Science ®Google Scholar
• van Meerwijk CLLI, Kuper J, van Straalen J, et al. Uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2023;31(10):1906–1914. doi:10.1080/09273948.2023.2278060.
   Web of Science ®Google Scholar
• Kochtali S, Ozdal P, AlBloushi A, et al. Pediatric pars planitis: a review. Ocul Immunol Inflamm. 2023;31(10):1915–1929. doi:10.1080/09273948.2023.2279683.
   Web of Science ®Google Scholar
• Janetos T, Lee PHA, Goldstein DA. Tubulointerstitial nephritis and uveitis syndrome in pediatric patients. Ocul Immunol Inflamm. 2023;31(10):1955–1964. doi: 10.1080/09273948.2023.2279689.
   PubMed Web of Science ®Google Scholar
• Smith JR, Mochizuki M. Sarcoid uveitis in children. Ocul Immunol Inflamm. 2023;31(10):1965–1970. doi: 10.1080/09273948.2023.2282609.
   Web of Science ®Google Scholar
• Maghsoudlou P, Abraham A, El-Ashry M, et al. Uveitis associated with monogenic autoinflammatory syndrome in children. Ocul Immunol Inflamm. 2023;31(10):1930–1943. doi:10.1080/09273948.2023.2282610.
   PubMed Web of Science ®Google Scholar
• Curi ALL, de-la-Torre A, Schlaen A, Mahendradas P, Biswas J. Pediatric posterior infectious uveitis. Ocul Immunol Inflamm. 2023;31(10):1944–1954. doi:10.1080/09273948.2023.2284990.
   Web of Science ®Google Scholar
• Sonmez HK, Evereklioglu C, Gulmez Sevim D. Prompt and sustained suppression of intraocular inflammation with adalimumab in pediatric patients with non-infectious uveitis resistant to traditional managements: a 6-month follow-up research. Ocul Immunol Inflamm. 2023;31(10):1992–1996. doi:10.1080/09273948.2022.2139274.
   PubMed Web of Science ®Google Scholar
• Hiyama T, Harada Y, Kiuchi Y. Efficacy and safety of adalimumab therapy for the treatment of non-infectious uveitis: efficacy comparison among uveitis aetiologies. Ocul Immunol Inflamm. 2022;30(4):951–958. doi:10.1080/09273948.2020.1857791.
   PubMed Web of Science ®Google Scholar
• Huard J, Mihailescu S-D, Muraine M, et al. Effectiveness and safety of weekly adalimumab for noninfectious chronic anterior uveitis in children. Ocul Immunol Inflamm. 2023;31(10):2039–2049. doi:10.1080/09273948.2023.2279682.
   PubMed Web of Science ®Google Scholar
• Marino A, Marelli L, Nucci P, Caporali R, Miserocchi E. Subcutaneous tocilizumab in juvenile idiopathic arthritis associated uveitis. Ocul Immunol Inflamm. January, 2023;31(10):1997–2000. doi:10.1080/09273948.2022.2161916.
   PubMed Web of Science ®Google Scholar
• van Meerwijk CLLI, Wieringa WG, de Boer JH, Jansonius NM, Los LI. Factors associated with glaucoma surgery in pediatric non-infectious uveitis. Ocul Immunol Inflamm. January, 2023;31(10):2018–2023. doi:10.1080/09273948.2023.2166849.
   PubMed Web of Science ®Google Scholar
• Gunay M, Uzlu D, Akyol N. Outcomes of gonioscopy-assisted transluminal trabeculotomy as a primary surgical treatment for glaucoma secondary to juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2023;31(10):2060–2064. doi:10.1080/09273948.2023.2221965.
   PubMed Web of Science ®Google Scholar
• Glandorf K, Rothaus K, Baquet-Walscheid K, Heinz C, Heiligenhaus A. Surgical glaucoma treatment in patients with juvenile idiopathic arthritis-associated uveitis: results after trabeculectomy or Ahmed glaucoma valve implantation. Ocul Immunol Inflamm. 2023:1–6. doi:10.1080/09273948.2023.2185263.
   PubMed Web of Science ®Google Scholar
• Sadhu S, Dutta Majumder P, Shah M, George R. Vogt-Koyanagi-Harada disease in pre-school children. Ocul Immunol Inflamm. 2022:1–4. doi:10.1080/09273948.2022.2117707.
   PubMedGoogle Scholar
• Hassan LM, Hassan MM, Abou Shady H, Khedr D. VKH with APECED in a two-year-old child: a rare concomitant diagnosis in an unprecedented age. Ocul Immunol Inflamm. 2023:1–4. doi:10.1080/09273948.2023.2208212.
   Web of Science ®Google Scholar
• Rego-Lorca D, Català-Mora J, López-de-Eguileta A, Díaz-Cascajosa J. Spontaneous regression of choroidal neovascularization in a girl with rubella retinopathy. Ocul Immunol Inflamm. 2023;31(10):2069–2071. doi:10.1080/09273948.2023.2233610.
   PubMed Web of Science ®Google Scholar
• Shen Y, Gong Y, Su L. Diagnostic challenges in PD-1 inhibitor induced panuveitis in a teenage girl with chest soft tissue sarcoma - a case report. Ocul Immunol Inflamm. 2023;31(10):2065–2068. doi:10.1080/09273948.2023.2233015.
   Web of Science ®Google Scholar
• Upadhyaya A, Jalali S, Tyagi M, Parameswarappa DC. Intravitreal clindamycin as an adjuvant therapy in congenital toxoplasma retinochoroiditis in a neonate – a case report. Ocul Immunol Inflamm. 2023:1–4. doi:10.1080/09273948.2023.2171890.
   PubMed Web of Science ®Google Scholar
• Testi I, Brandão-de-Resende C, De-La-Torre A, et al. Ocular inflammatory events following COVID-19 vaccination in the paediatric population: a multinational case series. Ocul Immunol Inflamm. 2023;1–6. doi:10.1080/09273948.2023.2220782.
   PubMed Web of Science ®Google Scholar